Substance Use and Addiction Journal

Aims & Scope

The mission of Substance Use & Addiction Journal (SAJ) is to advance science through dissemination of high-quality, innovative research, and commentary related to substance use and substance use disorders by and for a broad range of stakeholders including clinicians, researchers, educators, policy makers, persons and advocates of persons who use substances, and public health and healthcare staff and leaders worldwide.

SAJ is committed to improving health, health care, and health equity for vulnerable populations.

SAJ strives to obtain, publish, and promote high-quality, innovative research, and commentary regarding substance use and substance use disorder in the following thematic areas: 1.

Substance use and substance use disorder prevention, identification, assessment, treatment, and recovery [clinical theme] 2.

Innovations and evaluation of education and training modalities regarding substance use and substance use disorder for the community, students, trainees, and health care professionals [education theme] 3.

The impact, influence, prevention, and treatment of substance use, and substance use disorders among vulnerable, marginalized, and/or populations that suffer health inequity [equity theme] 4.

The impact, influence, prevention, and treatment of substance use, and substance use disorders within the international community [international theme] 5.

Substance use and substance use disorder health policy and public health research [policy/public health theme] 6.

Implementation of evidence-based prevention, identification, assessment, and treatment within health care, community, and geographic environments [implementation theme] 7.

Innovative methods to evaluate substance use and substance use prevention, harm reduction, identification, assessment, treatment, and recovery [harm reduction theme]

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	1.011

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	62

Journal Rank

Year	Value
2024	4737

Journal Citation Indicator

Year	Value
2024	995

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Xylazine-Associated Wounds and Related Health Concerns Among People Who Use Drugs: Reports From Front-Line Health Workers in 7 US States

  Citation: 15

  Authors: Jennifer J.

• Relationships Between Stigma, Risk Tolerance, and Buprenorphine Dispensing Intentions Among Community-Based Pharmacists: Results From a National Sample

  Citation: 11

  Authors: Alysson E., Traci C., Patricia R., Paria Sanaty, Anne L., Lucas G.

• Xylazine and Adulterants in the Evolving Drug Supply: Urgent Call for Responsive Education Models

  Citation: 9

  Authors: Raagini, Stephen, Samantha, Alicia S., Tavita, Alexa, Margaret, Colleen

• Exploring Xylazine Awareness, Health Impacts, and Harm Reduction Strategies: Findings From a Multimethods Study in Lowell, Massachusetts

  Citation: 9

  Authors: Shikhar, Kevin, Grace, Jaime, Takkyung, Jennifer, Thomas J.

• Electronic-Screening, Brief Intervention and Referral to Treatment (e-SBIRT) for Addictive Disorders: Systematic Review and Meta-Analysis

  Citation: 7

  Authors: Matthew, Christopher J., Simon

• Methadone’s Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction)

  Citation: 7

  Authors: Leslie W., Michael, Caty, Honora, Jeffrey, Gail, Rachel

• Naloxone Distribution Models in the United States: A Scoping Review

  Citation: 7

  Authors: Nina, David R., Becka

• Connecting Chronic Pain and Opioid Use Disorder Clinical Trials Through Data Harmonization: Wake Forest IMPOWR Dissemination, Education, and Coordination Center (IDEA-CC)

  Citation: 7

  Authors: Meredith C. B., Robert W., Umit

• A Systematic Review of State Office-Based Buprenorphine Treatment Laws Effective During 2022: Counseling, Dosage, and Visit Frequency Requirements

  Citation: 7

  Authors: Barbara, Olivia K., Michelle, Scott, Adam J., Bradley D.

• Mental Health Distress Is Associated With Higher Pain Interference in Patients With Opioid Use Disorder Stabilized on Buprenorphine or Methadone

  Citation: 7

  Authors: Sarah, Cynthia J., Dana D., Kenneth C., Judith I., Joseph O.

---